Mega Lifesciences Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Vivek Dhawan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 37yrs |
| CEO ownership | 6.6% |
| Management average tenure | 27yrs |
| Board average tenure | 11.9yrs |
Recent management updates
Recent updates
CEO
Vivek Dhawan (63 yo)
37yrs
Tenure
Mr. Vivek Dhawan is CEO, Chief Coach & Executive Director of Mega Lifesciences Public Company Limited from 2013. He joined the Mega Lifesciences Public Company Limited in 1986. He is CEO & Chief Coach of M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Coach & Executive Director | 37yrs | no data | 6.59% THB 2.0b | |
| CFO & Executive Director | 27yrs | no data | 0.76% THB 230.1m | |
| Chief Risk & Compliance Officer | no data | no data | no data | |
| President of International | no data | no data | 1.5% THB 451.4m | |
| President of Myanmar | no data | no data | no data | |
| Deputy Chief Financial Officer | 5yrs | no data | 0.000010% THB 3.0k | |
| President of Mega We Care Thailand | no data | no data | 1.48% THB 444.5m | |
| Corporate Secretary | no data | no data | 0.019% THB 5.9m |
27.0yrs
Average Tenure
57.5yo
Average Age
Experienced Management: MEGA-R's management team is seasoned and experienced (27 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Coach & Executive Director | 12yrs | no data | 6.59% THB 2.0b | |
| CFO & Executive Director | 27yrs | no data | 0.76% THB 230.1m | |
| Independent Vice Chairma | 11.9yrs | ฿1.58m | no data | |
| Non-Executive Director | 11.9yrs | ฿661.50k | 49.81% THB 15.0b | |
| Non-Executive Director | 11.9yrs | ฿661.50k | no data | |
| Non-Executive Director | 11.9yrs | ฿661.50k | 0.32% THB 96.1m | |
| Independent Chairman | 11.9yrs | ฿2.21m | no data | |
| Non-Executive Director | 11.9yrs | ฿661.50k | no data | |
| Independent Director | 11.9yrs | ฿1.15m | 0.022% THB 6.6m | |
| Independent Director | 3.7yrs | ฿1.15m | no data | |
| Independent Director | 2yrs | ฿1.15m | no data |
11.9yrs
Average Tenure
61yo
Average Age
Experienced Board: MEGA-R's board of directors are seasoned and experienced ( 11.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 02:03 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mega Lifesciences Public Company Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuwanee Prommaporn | BNP Paribas Securities (Asia) |
| Graham Price | CGS International |
| null null | DBS Bank Ltd |